The high-density lipoprotein receptor Scarb1 is required for normal bone differentiation in vivo and in vitro.
Journal
Laboratory investigation; a journal of technical methods and pathology
ISSN: 1530-0307
Titre abrégé: Lab Invest
Pays: United States
ID NLM: 0376617
Informations de publication
Date de publication:
12 2019
12 2019
Historique:
received:
23
04
2019
accepted:
15
07
2019
revised:
20
06
2019
pubmed:
31
8
2019
medline:
1
7
2020
entrez:
31
8
2019
Statut:
ppublish
Résumé
We examined bone formation and turnover in high-density lipoprotein (HDL) receptor, scavenger receptor type I (Scarb1), knockout animals relative to wild-type (WT) controls. Scarb1
Identifiants
pubmed: 31467425
doi: 10.1038/s41374-019-0311-0
pii: S0023-6837(22)00555-4
doi:
Substances chimiques
Scarb1 protein, mouse
0
Scavenger Receptors, Class B
0
Adrenocorticotropic Hormone
9002-60-2
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
1850-1860Subventions
Organisme : BLRD VA
ID : I01 BX002490
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR053976
Pays : United States
Commentaires et corrections
Type : ErratumIn
Références
Shen WJ, Hu J, Hu Z, Kraemer FB, Azhar S. Scavenger receptor class B type I (SR-BI): a versatile receptor with multiple functions and actions. Metabolism. 2014;63:875–86.
doi: 10.1016/j.metabol.2014.03.011
Blair HC, Kalyvioti E, Papachristou NI, Tourkova IL, Syggelos SA, Deligianni D, et al. Apolipoprotein A-1 regulates osteoblast and lipoblast precursor cells in mice. Lab Invest. 2016;96:763–72.
doi: 10.1038/labinvest.2016.51
Papachristou NI, Blair HC, Kypreos KE, Papachristou DJ. High-density lipoprotein (HDL) metabolism and bone mass. J Endocrinol. 2017;233:R95–107.
doi: 10.1530/JOE-16-0657
Papachristou NI, Blair HC, Kalyvioti ES, Syggelos SA, Karavia EA, Kontogeorgakos V, et al. Western-type diet differentially modulates osteoblast, osteoclast, and lipoblast differentiation and activation in a background of APOE deficiency. Lab Invest. 2018;98:1516–26.
doi: 10.1038/s41374-018-0107-7
Isales CM, Zaidi M, Blair HC. ACTH is a novel regulator of bone mass. Ann N Y Acad Sci. 2010;1192:110–6.
doi: 10.1111/j.1749-6632.2009.05231.x
Martineau C, Martin-Falstrault L, Brissette L, Moreau R. The atherogenic Scarb1 null mouse model shows a high bone mass phenotype. Am J Physiol Endocrinol Metab. 2014;306:E48–57.
doi: 10.1152/ajpendo.00421.2013
Zaidi M, Sun L, Robinson LJ, Tourkova IL, Liu L, Wang Y, et al. ACTH protects against glucocorticoid- induced osteonecrosis of bone. Proc Natl Acad Sci USA. 2010;107:8782–7.
doi: 10.1073/pnas.0912176107
Tourkova IL, Liu L, Sutjarit N, Larrouture QC, Luo J, Robinson LJ, et al. Adrenocorticotropic hormone and 1,25-dihydroxyvitamin D(3) enhance human osteogenesis in vitro by synergistically accelerating the expression of bone-specific genes. Lab Invest. 2017;97:1072–83.
doi: 10.1038/labinvest.2017.62
Martineau C, Martin-Falstrault L, Brissette L, Moreau R. Gender- and region-specific alterations in bone metabolism in Scarb1-null female mice. J Endocrinol. 2014;222:277–88.
doi: 10.1530/JOE-14-0147
Martineau C, Kevorkova O, Brissette L, Moreau R. Scavenger receptor class B, type I (Scarb1) deficiency promotes osteoblastogenesis but stunts terminal osteocyte differentiation. Physiol Rep. 2014;2:e12117.
doi: 10.14814/phy2.12117
Dobrowolski SF, Tourkova IL, Robinson LJ, Secunda C, Spridik K, Blair HC. A bone mineralization defect in the Pah(enu2) model of classical phenylketonuria involves compromised mesenchymal stem cell differentiation. Mol Genet Metab. 2018;125:193–9.
doi: 10.1016/j.ymgme.2018.08.010
Bustin SA. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol. 2000;25:169–93.
doi: 10.1677/jme.0.0250169
Hoekstra M, Meurs I, Koenders M, Out R, Hildebrand RB, Kruijt JK, et al. Absence of HDL cholesteryl ester uptake in mice via SR-BI impairs an adequate adrenal glucocorticoid-mediated stress response to fasting. J Lipid Res. 2008;49:738–45.
doi: 10.1194/jlr.M700475-JLR200
Guo W, Li F, Zhu C, Wang B, Wang K, Dai C, et al. Effect of hypercortisolism on bone mineral density and bone metabolism: a potential protective effect of adrenocorticotropic hormone in patients with Cushing’s disease. J Int Med Res. 2018;46:492–503.
doi: 10.1177/0300060517725660
Dailiana ZH, Stefanou N, Khaldi L, Dimakopoulos G, Bowers JR, Fink C, et al. Vascular endothelial growth factor for the treatment of femoral head osteonecrosis: An experimental study in canines. World J Orthop. 2018;9:120–9.
doi: 10.5312/wjo.v9.i9.120
Premkumar M, Dhanwal DK, Mathews S, Garg A, Sahoo S, Mahamine K, et al. Avascular osteonecrosis of femoral head in a postoperative patient of pituitary Cushing’s disease. J Assoc Physicians India. 2013;61:413–5.
pubmed: 24640210
Kyriacou A, Stepien KM, Issa B. Urinary steroid metabolites in a case of florid Ectopic Cushing’s syndrome and clinical correlations. Hormones (Athens). 2016;15:540–7.
doi: 10.1007/BF03401411
Ackert-Bicknell CL. HDL cholesterol and bone mineral density: is there a genetic link? Bone. 2012;50:525–33.
doi: 10.1016/j.bone.2011.07.002
Tintut Y, Demer LL. Effects of bioactive lipids and lipoproteins on bone. Trends Endocrinol Metab. 2014;25:53–9.
doi: 10.1016/j.tem.2013.10.001
Park D, Spencer JA, Koh BI, Kobayashi T, Fujisaki J, Clemens TL, et al. Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration. Cell Stem Cell. 2012;10:259–72.
doi: 10.1016/j.stem.2012.02.003
Feigenson M, Eliseev RA, Jonason JH, Mills BN, O’Keefe RJ. PGE2 receptor subtype 1 (EP1) regulates mesenchymal stromal cell osteogenic differentiation by modulating cellular energy metabolism. J Cell Biochem. 2017;118:4383–93.
doi: 10.1002/jcb.26092
Kushwaha P, Wolfgang MJ, Riddle RC. Fatty acid metabolism by the osteoblast. Bone. 2018;115:8–14.
doi: 10.1016/j.bone.2017.08.024
Li H, Guo H, Li H. Cholesterol loading affects osteoblastic differentiation in mouse mesenchymal stem cells. Steroids. 2013;78:26–33.
doi: 10.1016/j.steroids.2012.10.013
Viccica G, Vignali E, Marcocci C. Role of the cholesterol biosynthetic pathway in osteoblastic differentiation. J Endocrinol Invest. 2007;30(6 Suppl):8–12.
pubmed: 17721067